Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1998 1
2001 3
2003 2
2004 2
2005 3
2006 4
2007 1
2008 3
2009 6
2010 10
2011 6
2012 13
2013 14
2014 15
2015 13
2016 17
2017 15
2018 14
2019 14
2020 7
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 28663267

135 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of Gadoterate Meglumine and Gadobutrol in the MRI Diagnosis of Primary Brain Tumors: A Double-Blind Randomized Controlled Intraindividual Crossover Study (the REMIND Study).
Maravilla KR, San-Juan D, Kim SJ, Elizondo-Riojas G, Fink JR, Escobar W, Bag A, Roberts DR, Hao J, Pitrou C, Tsiouris AJ, Herskovits E, Fiebach JB. Maravilla KR, et al. AJNR Am J Neuroradiol. 2017 Sep;38(9):1681-1688. doi: 10.3174/ajnr.A5316. Epub 2017 Jun 29. AJNR Am J Neuroradiol. 2017. PMID: 28663267 Free article. Clinical Trial.
Cerebral neoplastic enhancing lesions: multicenter, randomized, crossover intraindividual comparison between gadobutrol (1.0M) and gadoterate meglumine (0.5M) at 0.1 mmol Gd/kg body weight in a clinical setting.
Anzalone N, Scarabino T, Venturi C, Cristaudo C, Tartaro A, Scotti G, Zimatore D, Floris R, Carriero A, Longo M, Cirillo M, Cova MA, Gatti S, Voth M, Colosimo C. Anzalone N, et al. Eur J Radiol. 2013 Jan;82(1):139-45. doi: 10.1016/j.ejrad.2011.07.005. Epub 2011 Sep 3. Eur J Radiol. 2013. PMID: 21890295 Clinical Trial.
MR Angiography at 3 T of Peripheral Arterial Disease: A Randomized Prospective Comparison of Gadoterate Meglumine and Gadobutrol.
Loewe C, Arnaiz J, Krause D, Marti-Bonmati L, Haneder S, Kramer U; DALIA Study Group. Loewe C, et al. AJR Am J Roentgenol. 2015 Jun;204(6):1311-21. doi: 10.2214/AJR.14.12604. AJR Am J Roentgenol. 2015. PMID: 26001243 Clinical Trial.
The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).
Vaneckova M, Herman M, Smith MP, Mechl M, Maravilla KR, Weichet J, Spampinato MV, Žižka J, Wippold FJ 2nd, Baima JJ, Babbel R, Bültmann E, Huang RY, Buhk JH, Bonafé A, Colosimo C, Lui S, Kirchin MA, Shen N, Pirovano G, Spinazzi A. Vaneckova M, et al. AJNR Am J Neuroradiol. 2015 Sep;36(9):1589-98. doi: 10.3174/ajnr.A4468. Epub 2015 Jul 16. AJNR Am J Neuroradiol. 2015. PMID: 26185325 Free article. Clinical Trial.
MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
Saake M, Langner S, Schwenke C, Weibart M, Jansen O, Hosten N, Doerfler A. Saake M, et al. Eur Radiol. 2016 Mar;26(3):820-8. doi: 10.1007/s00330-015-3889-7. Epub 2015 Jun 30. Eur Radiol. 2016. PMID: 26123410 Clinical Trial.
Contrast-to-Dose Relationship of Gadopiclenol, an MRI Macrocyclic Gadolinium-based Contrast Agent, Compared with Gadoterate, Gadobenate, and Gadobutrol in a Rat Brain Tumor Model.
Robert P, Vives V, Grindel AL, Kremer S, Bierry G, Louin G, Ballet S, Corot C. Robert P, et al. Radiology. 2020 Jan;294(1):117-126. doi: 10.1148/radiol.2019182953. Epub 2019 Oct 29. Radiology. 2020. PMID: 31660804
Comparative evaluation of lesion enhancement using 1 M gadobutrol vs. 2 conventional gadolinium chelates, all at a dose of 0.1 mmol/kg, in a rat brain tumor model at 3 T.
Attenberger UI, Runge VM, Jackson CB, Baumann S, Birkemeier K, Michaely HJ, Schoenberg SO, Reiser MF, Wintersperger BJ. Attenberger UI, et al. Invest Radiol. 2009 May;44(5):251-6. doi: 10.1097/RLI.0b013e31819ba711. Invest Radiol. 2009. PMID: 19550376
Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose.
Kramer JH, Arnoldi E, François CJ, Wentland AL, Nikolaou K, Wintersperger BJ, Grist TM. Kramer JH, et al. Invest Radiol. 2013 Mar;48(3):121-8. doi: 10.1097/RLI.0b013e31827752b4. Invest Radiol. 2013. PMID: 23211552 Free PMC article. Clinical Trial.
Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study).
Seidl Z, Vymazal J, Mechl M, Goyal M, Herman M, Colosimo C, Pasowicz M, Yeung R, Paraniak-Gieszczyk B, Yemen B, Anzalone N, Citterio A, Schneider G, Bastianello S, Ruscalleda J. Seidl Z, et al. AJNR Am J Neuroradiol. 2012 Jun;33(6):1050-8. doi: 10.3174/ajnr.A3033. Epub 2012 Mar 1. AJNR Am J Neuroradiol. 2012. PMID: 22383237 Free article. Clinical Trial.
Magnetic resonance evaluation of brain metastases from systemic malignances with two doses of gadobutrol 1.0 m compared with gadoteridol: a multicenter, phase ii/iii study in patients with known or suspected brain metastases.
Katakami N, Inaba Y, Sugata S, Tsurusaki M, Itoh T, Machida T, Tanaka H, Nakayama T, Morikawa T, Breuer J, Aitoku Y. Katakami N, et al. Invest Radiol. 2011 Jul;46(7):411-8. doi: 10.1097/RLI.0b013e3182145a6c. Invest Radiol. 2011. PMID: 21467949 Clinical Trial.
135 results
Jump to page
Feedback